Skip to main content

2015 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
12/09/15Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Dec. 9, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 24 cents per share on Bard's common stock. The current indicated annual dividend rate is 96 cents per share. The dividend is payable on February 5, 2016 to shareholders of record at the close of business on January 25, 2016. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N... 
Printer Friendly Version
11/24/15Bard to Present at the Piper Jaffray Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Nov. 24, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Piper Jaffray Healthcare Conference in New York City on December 1, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 11:30 AM Eastern Standard Time. A live webcast of Bard's presentation will be accessible to all investors through Bard’s webs... 
Printer Friendly Version
11/20/15Bard Agrees to Acquire Liberator Medical
MURRAY HILL, N.J.--(BUSINESS WIRE)--Nov. 20, 2015-- C. R. Bard, Inc. (NYSE: BCR) announced today that it has entered into a definitive agreement to acquire Liberator Medical Holdings, Inc. (NYSEMKT: LBMH) (Liberator) for $3.35 per share, or approximately $181 million. This transaction is structured as a merger, has been approved by each company’s board of directors, and is subject to customary closing conditions, including approval of the shareholders of... 
Printer Friendly Version
11/10/15Bard to Present at the Stifel Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Nov. 10, 2015-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Stifel Healthcare Conference in New York City on November 17, 2015. John H. Weiland, president and chief operating officer, will discuss the company in a presentation scheduled to begin at 4:30 PM Eastern Standard Time. A live webcast of Bard's presentation and question and answer session will be accessible to all in... 
Printer Friendly Version
10/22/15Bard Announces Third Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 22, 2015-- C. R. Bard, Inc. (NYSE:BCR) today reported 2015 third quarter financial results. Third quarter 2015 net sales were $865.7 million, an increase of 4 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, third quarter 2015 net sales increased 8 percent over the prior-year period. For the third quarter 2015, net sales in the U.S. were $606.5 million, ... 
Printer Friendly Version
10/14/15Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 14, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 24 cents per share on Bard's common stock. The current indicated annual dividend rate is 96 cents per share. The dividend is payable on November 6, 2015 to shareholders of record at the close of business on October 26, 2015. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, ... 
Printer Friendly Version
10/12/15Lutonix® Global Real-World Registry Outcomes Presented at TCT 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 12, 2015-- C. R. Bard, Inc. (NYSE:BCR) announced today the presentation of the 12-month results from the Lutonix® Global Real-World Registry at the Transcatheter Cardiovascular Therapeutics (TCT) 2015 meeting. These results come just months after publication in the New England Journal of Medicine of the 1-year data from the Lutonix® 035 Drug Coated Balloon (DCB) Catheter pivotal, randomized LEVANT 2 trial. ... 
Printer Friendly Version
10/01/15Bard to Host Earnings Conference Call on October 22, 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 1, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, October 22, 2015 at 5:00 PM EDT, to discuss the company’s third quarter 2015 operating results, and to provide financial guidance for the fourth quarter of 2015. Bard is scheduled to issue an earnings press release after the market closes on October 22, 2015. A live audio webcast of Bard's investor... 
Printer Friendly Version
09/30/15Bard Agrees to Acquire Full Ownership of its Joint Venture in Japan
MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 30, 2015-- C. R. Bard, Inc. (NYSE:BCR) announced today that it has entered into a definitive agreement to acquire Kobayashi Pharmaceutical Co., Ltd.’s (Kobayashi) 50% ownership share in Medicon, Inc. (Medicon), the Osaka, Japan-based joint venture that the two companies have operated together since 1972, through a share redemption. The transaction is expected to close in early November 2015, after which Medicon wi... 
Printer Friendly Version
09/10/15Bard to Present at Morgan Stanley Global Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 10, 2015-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Morgan Stanley Global Healthcare Conference in New York City on September 17, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 1:30 PM Eastern Daylight Time. A live webcast of Bard's presentation will be accessible to all investors through B... 
Printer Friendly Version
08/03/15CMS Approves Add-on Payment for Lutonix® Drug-Coated Balloon for Inpatient Use
MURRAY HILL, N.J.--(BUSINESS WIRE)--Aug. 3, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment for the Lutonix® Drug-Coated Balloon (DCB) under the Medicare hospital inpatient prospective payment system. The purpose of the reimbursement is to help cover additional cost to U.S. hospitals for treating Medicare beneficiaries with the Lutonix® D... 
Printer Friendly Version
07/23/15Bard Announces Second Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 23, 2015-- C. R. Bard, Inc. (NYSE:BCR) today reported 2015 second quarter financial results. Second quarter 2015 net sales were $859.8 million, an increase of 4 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, second quarter 2015 net sales increased 8 percent over the prior-year period. For the second quarter 2015, net sales in the U.S. were $592.0 milli... 
Printer Friendly Version
07/01/15Bard to Host Earnings Conference Call on July 23, 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 1, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, July 23, 2015 at 5:00 PM EDT, to discuss the company’s second quarter 2015 operating results, and to provide financial guidance for the third quarter of 2015. Bard is scheduled to issue an earnings press release after the market closes on July 23, 2015. A live audio webcast of Bard's investor conference w... 
Printer Friendly Version
06/25/15 The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 25, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced the publication of results from the LEVANT 2 study in the June 24, 2015 online issue of The New England Journal of Medicine. Results from LEVANT 2 demonstrated superior primary patency for Lutonix® 035 Drug Coated Balloon PTA Catheter (Lutonix® DCB) over standard percutaneous transluminal angioplasty (PTA), as well as safety consistent with standard PTA... 
Printer Friendly Version
06/10/15Bard Announces $500 Million Share Repurchase Authorization
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 10, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE: BCR) today authorized the repurchase of up to $500 million of the company’s common stock. This is in addition to approximately $160 million remaining under the prior authorization announced in June 2014. Share repurchases will be made from time-to-time in the open market or through privately negotiated transactions. C. R. Bard, Inc. (www.c... 
Printer Friendly Version
06/10/15Bard Increases Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 10, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today increased the quarterly dividend on Bard's common stock by 9 percent, to 24 cents per share. The dividend is payable on July 31, 2015 to shareholders of record at the close of business on July 20, 2015. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and ma... 
Printer Friendly Version
06/09/15CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 9, 2015-- C. R. Bard, Inc. (NYSE: BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix® drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system. The purpose of the reimbursement is to cover additional cost to U.S. hospitals for treating Medicare beneficiaries with the Lutonix DCB in the outpatie... 
Printer Friendly Version
05/26/15Bard to Present at Jefferies Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--May 26, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Jefferies Healthcare Conference in New York City on June 2, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 1:30 PM Eastern Daylight Time. A live webcast of Bard's presentation will be accessible to all investors through Bard’s website at htt... 
Printer Friendly Version
05/05/15Bard to Present at the Bank of America Merrill Lynch Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--May 5, 2015-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas, Nevada on May 12, 2015. Christopher S. Holland, senior vice president and chief financial officer, will discuss the company in a presentation scheduled to begin at 4:20 PM Pacific Daylight Time. A live webcast of Bard's presentation will be accessible to all ... 
Printer Friendly Version
04/23/15Bard Announces First Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 23, 2015-- C. R. Bard, Inc. (NYSE: BCR) today reported 2015 first quarter financial results. First quarter 2015 net sales were $819.7 million, an increase of 3 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, first quarter 2015 net sales increased 5 percent over the prior-year period. For the first quarter 2015, net sales in the U.S. were $574.1 million,... 
Printer Friendly Version
04/15/15Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 15, 2015-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on May 8, 2015 to shareholders of record at the close of business on April 27, 2015. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is ... 
Printer Friendly Version
04/01/15Bard to Host Earnings Conference Call on April 23, 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 1, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, April 23, 2015 at 5:00 PM EDT, to discuss the company’s first quarter 2015 operating results, and to provide financial guidance for the second quarter of 2015. Bard is scheduled to issue an earnings press release after the market closes on April 23, 2015. A live audio webcast of Bard's investor con... 
Printer Friendly Version
03/04/15Bard to Present at Barclays Global Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Mar. 4, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Barclays Global Healthcare Conference in Miami, Florida on March 11, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 2:50 PM Eastern Daylight Time. A live webcast of Bard's presentation will be accessible to all investors through Bard’s websi... 
Printer Friendly Version
02/25/15Bard to Present at Raymond James Institutional Investors Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Feb. 25, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Raymond James Institutional Investors Conference in Orlando, Florida on March 4, 2015. Christopher S. Holland, senior vice president and chief financial officer, will discuss the Company in a presentation scheduled to begin at 11:00 AM Eastern Standard Time. A live webcast of Bard's presentation will be accessible to all ... 
Printer Friendly Version
02/19/15CMS Approves Pass-Through Payment for Lutonix DCB for Outpatient Use
MURRAY HILL, N.J.--(BUSINESS WIRE)--Feb. 19, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix® drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system. This approval follows a unanimous favorable recommendation from the FDA’s Circulatory Systems Devices Advisory Panel, which voted 9 to 0 on each question... 
Printer Friendly Version
02/09/15Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon
Agreement Extends Reach of Lutonix DCB and Provides Physicians with a Comprehensive Solution to Prepare and Treat Diseased Femoropopliteal Vessels MARLBOROUGH, Mass., and MURRAY HILL, N.J., Feb. 9, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard") today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States under a limit... 
Printer Friendly Version
01/29/15Bard Announces Fourth Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 29, 2015-- C. R. Bard, Inc. (NYSE:BCR) today reported 2014 fourth quarter financial results. Fourth quarter 2014 net sales were $867.2 million, an increase of 10 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, fourth quarter 2014 net sales increased 11 percent over the prior-year period. For the fourth quarter 2014, net sales in the U.S. were $591.6 mil... 
Printer Friendly Version
01/06/15Bard to Host Earnings Conference Call on January 29, 2015
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 6, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, January 29, 2015 at 5:00 PM EST, to discuss the company’s fourth quarter and full year 2014 operating results, and to provide financial guidance for 2015. Bard is scheduled to issue an earnings press release after the market closes on January 29, 2015. A live audio webcast of Bard's investor conference wi... 
Printer Friendly Version
01/06/15Bard to Present at J.P. Morgan Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 6, 2015-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the J.P. Morgan Healthcare Conference in San Francisco, California on January 13, 2015. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 2:30 PM Pacific Standard Time. A live webcast of Bard's presentation and question and answer session will be accessi... 
Printer Friendly Version
Print Page Print Page | E-mail Page E-mail Page